Table 3. Association between lifestyle factors and family history and ovarian cancer-specific survival.
| OC deaths/na | HR model 1b | 95% CI | P-value | OC deaths/nc | HR model 2d | 95% CI | P-value | |
|---|---|---|---|---|---|---|---|---|
| Lifestyle factors/family history | ||||||||
| Smoking, never/ever | ||||||||
| Never | 274/661 | 1.00 | Ref. | Ref. | 159/372 | 1.00 | Ref. | Ref. |
| Ever | 312/640 | 1.16 | 0.99, 1.36 | 0.08 | 211/393 | 1.25 | 1.01, 1.54 | 0.04 |
| BMI 5 years before diagnosis (kg m−2), continuous (5-unit increases) | 584/1294 | 1.11 | 1.03, 1.19 | 0.006 | 367/758 | 1.17 | 1.07, 1.28 | 0.0007 |
| BMI 5 years before diagnosis (kg m−2) | ||||||||
| <18.5 | 10/20 | 1.10 | 0.58, 2.07 | 0.77 | 5/9 | 0.99 | 0.40, 2.42 | 0.97 |
| 18.5–<25 | 288/660 | 1.00 | Ref. | Ref. | 178/383 | 1.00 | Ref. | Ref. |
| 25–<30 | 179/388 | 1.10 | 0.92, 1.33 | 0.30 | 112/229 | 1.13 | 0.89, 1.44 | 0.31 |
| ⩾30 | 107/226 | 1.22 | 0.97, 1.52 | 0.08 | 72/137 | 1.34 | 1.02, 1.76 | 0.04 |
| BRCA1/2 mutation | ||||||||
| No | 539/1224 | 1.00 | Ref. | Ref. | 341/725 | 1.00 | Ref. | Ref. |
| Yes | 99/170 | 1.19 | 0.95, 1.48 | 0.13 | 63/108 | 1.05 | 0.80, 1.40 | 0.72 |
| First-degree relative with breast cancer | ||||||||
| No | 498/1105 | 1.00 | Ref. | Ref. | 317/668 | 1.00 | Ref. | Ref. |
| Yes | 123/257 | 1.05 | 0.86, 1.28 | 0.64 | 78/146 | 0.99 | 0.77, 1.28 | 0.95 |
| First-degree relative with ovarian cancer | ||||||||
| No | 568/1259 | 1.00 | Ref. | Ref. | 362/754 | 1.00 | Ref. | Ref. |
| Yes | 52/102 | 1.05 | 0.79, 1.40 | 0.73 | 32/59 | 1.03 | 0.71, 1.48 | 0.89 |
Abbreviations: BMI=body mass index; CI=confidence interval; HR=hazard ratio; OC=ovarian cancer; ref.=reference value.
There were a total of n=1394 in model 1 because 27 participants had missing information on tumour stage.
Adjusted for age at diagnosis (continuous), histology (serous, mucinous, endometrioid, clear cell, other), and stage (I, II, III, IV).
There were a total of n=833 in model 2 because 588 participants had missing information on residual disease after debulking surgery.
Adjusted for model 1 and residual disease (no residual disease, any residual disease).